ANIK
Anika Therapeutics Inc
NASDAQ: ANIK · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$12.39
-18.81% today
Updated 2026-04-29
Market cap
$221.65M
P/E ratio
—
P/S ratio
1.97x
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$8 – $16
Volume
0.1M
Anika Therapeutics Inc (ANIK) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-7.6%
Last 4 quarters
Revenue YoY growth
-2473.3%
Most recent quarter
EPS YoY growth
+1133.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-4.0%
2026-03-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-10 | $0.31 | +329.6% | $14.96 | $14.36 | -4.0% |
| 2025-10-29 | $0.04 | +136.4% | $9.74 | $9.78 | +0.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.14 | $0.31 | +329.6% | $30.61M | -2473.3% |
| 2025-09-30 | $-0.11 | $0.04 | +136.4% | $27.82M | -28.2% |
| 2025-06-30 | $-0.08 | $-0.33 | -312.5% | $28.22M | -8.2% |
| 2025-03-31 | $0.09 | $-0.06 | -166.7% | $26.17M | -35.4% |
| 2024-12-31 | $0.09 | $-0.03 | -133.3% | $-1.29M | -103.0% |
| 2024-09-30 | $-0.01 | $-0.25 | -2400.0% | $38.75M | -6.5% |
| 2024-06-30 | $0.05 | $-0.01 | -120.0% | $30.72M | -30.6% |
| 2024-03-31 | $-0.19 | $-0.31 | -63.2% | $40.52M | — |
| 2023-12-31 | $-0.26 | $-4.30 | -1553.8% | $42.97M | — |
| 2023-09-30 | $-0.37 | $-0.45 | -21.6% | $41.47M | — |
| 2023-06-30 | $-0.27 | $-0.19 | +29.6% | $44.30M | — |
| 2023-03-31 | $-0.30 | $-0.47 | -56.7% | — | — |
Frequently asked questions
Has Anika Therapeutics Inc beaten earnings estimates?
Anika Therapeutics Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -7.6% over the last 4 quarters.
How does ANIK stock react to earnings?
ANIK stock has moved an average of -1.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Anika Therapeutics Inc's revenue growth rate?
Anika Therapeutics Inc reported year-over-year revenue growth of -2473.3% in its most recent quarter, with EPS growing +1133.3% year-over-year.